BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:bfb336b6-7b27-40a8-a0c8-96d5f0ab291e
DTSTAMP:20250917T121109Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:f763634c-7735-48c6-8873-018cfd059c04
DTSTAMP:20250917T121109Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:49b71529-cdb9-427a-93c4-c7931faba656
DTSTAMP:20250917T121109Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:71a89ff7-22c7-4bfa-bd42-dcb08c4c77b0
DTSTAMP:20250917T121109Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:39cea0ba-e852-4eff-a00e-e9bf5b44046c
DTSTAMP:20250917T121109Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:a8270d0b-e49d-4796-98ad-8cc118138ac9
DTSTAMP:20250917T121109Z
DTSTART:20251021T090000Z
DTEND:20251021T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:LT G
END:VEVENT
BEGIN:VEVENT
UID:d02c5b59-5a02-4e4f-9702-35fe3ae3a75d
DTSTAMP:20250917T121109Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:a407bc66-9615-40fc-8a0a-465b17889cd1
DTSTAMP:20250917T121109Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:021d7b0c-7984-485e-9699-04bb5af2108f
DTSTAMP:20250917T121109Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:dfd4e8e2-cf8d-4d98-8e51-d95996a8ac8b
DTSTAMP:20250917T121109Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:b1567e2a-5f6a-4bfc-afb6-ad9df7144b3d
DTSTAMP:20250917T121109Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:01fe410d-a346-4704-99d0-6440832d971a
DTSTAMP:20250917T121109Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:0373e841-ad2d-44b4-b700-bcf3a908ed07
DTSTAMP:20250917T121109Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:0161f068-093a-43a1-89a5-b18e16455bfb
DTSTAMP:20250917T121109Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:19d05a33-e048-425e-8630-9d033cc50b77
DTSTAMP:20250917T121109Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:42c645a5-58ef-4142-a60f-105883cc2cb0
DTSTAMP:20250917T121109Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:8545bd79-42e6-44f2-9f22-508bf38cec8f
DTSTAMP:20250917T121109Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:654c41d4-55c5-4168-bc07-154db139ce4d
DTSTAMP:20250917T121109Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:560a82a8-4e52-46ee-a573-11ca424e10b4
DTSTAMP:20250917T121109Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
END:VCALENDAR
